Phenotypic Assay

Table P1. Single Targets Enriched Among Active molecules

  • kA:The number of active compounds known to target the gene
  • KA:The total number of active compounds(IC50 < 10-6)
  • kB:The number of inactive compounds known to target the gene
  • KB:The total number of inactive compounds(IC50 >10-6)
  • Odds Ratio: (kA/kB) / ( (KA-kA) / (KB - kB) )
# Target (Gene) P-value
FDR adjusted
Odds Ratio kA KA kB KB Polypharmacology
report
View
Compounds
details
View Target Profile
1 MITF 0. 79.5 456 1621 510 104122 Polypharmacology Molecules Target Profile
2 ATXN2 0. 75.1 421 1621 484 104122 Polypharmacology Molecules Target Profile
3 HSPA1A 5.09e-32 70.9 25 1621 23 104122 Polypharmacology Molecules Target Profile
4 EPAS1 0. 46.6 367 1621 650 104122 Polypharmacology Molecules Target Profile
5 HIF1A 1.85e-261 40.2 248 1621 466 104122 Polypharmacology Molecules Target Profile
6 CFTR 0. 33.1 336 1621 816 104122 Polypharmacology Molecules Target Profile
7 PLIN1 5.30e-17 32.4 16 1621 32 104122 Polypharmacology Molecules Target Profile
8 HNF4A 3.48e-181 31.6 185 1621 423 104122 Polypharmacology Molecules Target Profile
9 AGTR1 2.14e-27 30.4 27 1621 58 104122 Polypharmacology Molecules Target Profile
10 RAD52 5.97e-34 29.7 34 1621 75 104122 Polypharmacology Molecules Target Profile
11 OPRK1 6.04e-35 25.6 37 1621 95 104122 Polypharmacology Molecules Target Profile
12 SMAD3 7.72e-288 24.8 328 1621 1053 104122 Polypharmacology Molecules Target Profile
13 TNF 3.06e-157 24.6 176 1621 513 104122 Polypharmacology Molecules Target Profile
14 NCOA3 4.36e-96 24.1 107 1621 304 104122 Polypharmacology Molecules Target Profile
15 XBP1 7.24e-60 23.2 67 1621 193 104122 Polypharmacology Molecules Target Profile
16 NTSR1 1.64e-59 22.9 67 1621 196 104122 Polypharmacology Molecules Target Profile
17 IDH1 0. 22.4 476 1621 1901 104122 Polypharmacology Molecules Target Profile
18 NOD2 3.06e-157 21.6 186 1621 622 104122 Polypharmacology Molecules Target Profile
19 CXCR6 7.95e-96 21.5 112 1621 359 104122 Polypharmacology Molecules Target Profile
20 IL1B 0. 21.4 845 1621 5043 104122 Polypharmacology Molecules Target Profile
21 ADRB2 5.09e-137 20.0 167 1621 596 104122 Polypharmacology Molecules Target Profile
22 PAX8 2.80e-124 19.7 152 1621 545 104122 Polypharmacology Molecules Target Profile
23 NOD1 2.96e-213 19.6 266 1621 1030 104122 Polypharmacology Molecules Target Profile
24 NCOA2 6.10e-56 19.6 67 1621 228 104122 Polypharmacology Molecules Target Profile
25 CCR6 1.88e-120 19.1 149 1621 548 104122 Polypharmacology Molecules Target Profile
26 NCOA1 1.36e-40 18.8 49 1621 172 104122 Polypharmacology Molecules Target Profile
27 S1PR1 2.01e-78 17.9 99 1621 378 104122 Polypharmacology Molecules Target Profile
28 TLR9 2.60e-53 17.0 68 1621 267 104122 Polypharmacology Molecules Target Profile
29 S1PR4 6.64e-103 15.8 139 1621 616 104122 Polypharmacology Molecules Target Profile
30 RAD54L 2.00e-24 15.1 32 1621 139 104122 Polypharmacology Molecules Target Profile
31 HKDC1 4.22e-38 14.5 52 1621 238 104122 Polypharmacology Molecules Target Profile
32 ATM 5.75e-21 14.3 28 1621 128 104122 Polypharmacology Molecules Target Profile
33 GALR2 5.91e-136 14.2 196 1621 1000 104122 Polypharmacology Molecules Target Profile
34 GMNN 0. 13.8 682 1621 5220 104122 Polypharmacology Molecules Target Profile
35 JAK2 3.65e-140 13.5 208 1621 1123 104122 Polypharmacology Molecules Target Profile
36 FEN1 7.33e-41 13.1 59 1621 300 104122 Polypharmacology Molecules Target Profile
37 TLR4 3.77e-30 13.0 43 1621 217 104122 Polypharmacology Molecules Target Profile
38 VDR 7.93e-120 12.9 181 1621 1004 104122 Polypharmacology Molecules Target Profile
39 TNFRSF10B 4.77e-140 12.8 214 1621 1221 104122 Polypharmacology Molecules Target Profile
40 NPSR1 4.73e-153 12.5 238 1621 1410 104122 Polypharmacology Molecules Target Profile
41 MAP1LC3A 1.05e-121 12.4 188 1621 1087 104122 Polypharmacology Molecules Target Profile
42 UBE2N 4.69e-41 12.4 61 1621 327 104122 Polypharmacology Molecules Target Profile
43 TDP1 0. 12.4 1236 1621 21478 104122 Polypharmacology Molecules Target Profile
44 GPR55 5.04e-29 11.6 44 1621 249 104122 Polypharmacology Molecules Target Profile
45 MAP4K2 2.94e-126 11.6 204 1621 1280 104122 Polypharmacology Molecules Target Profile
46 NR5A2 3.53e-59 11.5 93 1621 547 104122 Polypharmacology Molecules Target Profile
47 APLNR 8.02e-54 11.4 85 1621 505 104122 Polypharmacology Molecules Target Profile
48 CASP1 1.10e-44 10.6 73 1621 461 104122 Polypharmacology Molecules Target Profile
49 S1PR2 6.69e-52 10.5 86 1621 555 104122 Polypharmacology Molecules Target Profile
50 PAFAH1B3 9.68e-27 10.1 44 1621 288 104122 Polypharmacology Molecules Target Profile
51 GPR35 8.27e-07 9.8 10 1621 66 104122 Polypharmacology Molecules Target Profile
52 NR2E3 3.40e-57 9.7 100 1621 703 104122 Polypharmacology Molecules Target Profile
53 MDM2 8.53e-11 9.7 17 1621 114 104122 Polypharmacology Molecules Target Profile
54 MCHR1 2.12e-43 9.3 77 1621 556 104122 Polypharmacology Molecules Target Profile
55 KLF5 1.09e-17 9.2 30 1621 213 104122 Polypharmacology Molecules Target Profile
56 NLRP1 3.81e-75 9.0 139 1621 1069 104122 Polypharmacology Molecules Target Profile
57 RBBP8 3.65e-39 8.9 71 1621 532 104122 Polypharmacology Molecules Target Profile
58 MMP14 4.61e-41 8.9 75 1621 567 104122 Polypharmacology Molecules Target Profile
59 NR2F2 8.44e-48 8.4 91 1621 730 104122 Polypharmacology Molecules Target Profile
60 STK33 1.47e-12 8.4 22 1621 170 104122 Polypharmacology Molecules Target Profile
61 NPBWR1 3.99e-74 8.0 149 1621 1295 104122 Polypharmacology Molecules Target Profile
62 GSTO1 7.54e-74 7.8 152 1621 1366 104122 Polypharmacology Molecules Target Profile
63 TNFSF10 1.90e-28 7.7 56 1621 479 104122 Polypharmacology Molecules Target Profile
64 LARGE 7.64e-16 7.7 30 1621 254 104122 Polypharmacology Molecules Target Profile
65 MLLT3 4.00e-12 7.5 23 1621 200 104122 Polypharmacology Molecules Target Profile
66 SIX1 1.34e-36 7.5 75 1621 672 104122 Polypharmacology Molecules Target Profile
67 KCNJ1 2.57e-75 7.4 161 1621 1524 104122 Polypharmacology Molecules Target Profile
68 APP 6.88e-101 7.3 222 1621 2211 104122 Polypharmacology Molecules Target Profile
69 GPR183 1.59e-56 7.2 122 1621 1165 104122 Polypharmacology Molecules Target Profile
70 USP1 7.60e-17 7.1 34 1621 312 104122 Polypharmacology Molecules Target Profile
71 BCL2A1 2.52e-10 7.1 20 1621 183 104122 Polypharmacology Molecules Target Profile
72 DCLRE1C 3.73e-11 7.0 22 1621 204 104122 Polypharmacology Molecules Target Profile
73 APAF1 1.27e-52 6.7 120 1621 1231 104122 Polypharmacology Molecules Target Profile
74 PRNP 1.33e-24 6.6 54 1621 538 104122 Polypharmacology Molecules Target Profile
75 OXTR 3.73e-23 6.6 51 1621 512 104122 Polypharmacology Molecules Target Profile
76 HTR1A 3.42e-30 6.5 68 1621 693 104122 Polypharmacology Molecules Target Profile
77 UCHL5 1.33e-16 6.5 36 1621 363 104122 Polypharmacology Molecules Target Profile
78 ASAP1 2.06e-11 6.5 24 1621 241 104122 Polypharmacology Molecules Target Profile
79 WRN 1.98e-24 6.4 55 1621 566 104122 Polypharmacology Molecules Target Profile
80 GAPDH 2.23e-42 6.4 99 1621 1047 104122 Polypharmacology Molecules Target Profile
81 HTR5A 1.83e-35 6.4 82 1621 860 104122 Polypharmacology Molecules Target Profile
82 NCF1 3.92e-28 6.3 65 1621 686 104122 Polypharmacology Molecules Target Profile
83 RGS4 1.11e-64 6.3 158 1621 1767 104122 Polypharmacology Molecules Target Profile
84 NLRP3 3.21e-20 6.2 46 1621 485 104122 Polypharmacology Molecules Target Profile
85 HTT 1.69e-107 6.2 275 1621 3325 104122 Polypharmacology Molecules Target Profile
86 BLM 7.68e-14 6.2 31 1621 329 104122 Polypharmacology Molecules Target Profile
87 APOBEC3F 1.34e-20 6.1 48 1621 520 104122 Polypharmacology Molecules Target Profile
88 NFE2L2 3.42e-101 6.0 265 1621 3282 104122 Polypharmacology Molecules Target Profile
89 MAPT 2.24e-106 5.9 284 1621 3609 104122 Polypharmacology Molecules Target Profile
90 PPP1CA 3.00e-40 5.9 101 1621 1165 104122 Polypharmacology Molecules Target Profile
91 CTSL1 1.19e-25 5.8 63 1621 718 104122 Polypharmacology Molecules Target Profile
92 GLP1R 1.06e-63 5.8 167 1621 2029 104122 Polypharmacology Molecules Target Profile
93 DNMT1 5.30e-37 5.6 96 1621 1152 104122 Polypharmacology Molecules Target Profile
94 MC4R 5.07e-62 5.6 167 1621 2090 104122 Polypharmacology Molecules Target Profile
95 NFKB1 2.58e-14 5.6 35 1621 410 104122 Polypharmacology Molecules Target Profile
96 S1PR3 1.22e-11 5.5 28 1621 329 104122 Polypharmacology Molecules Target Profile
97 VCP 9.52e-14 5.5 34 1621 405 104122 Polypharmacology Molecules Target Profile
98 HTR1E 4.65e-30 5.5 79 1621 966 104122 Polypharmacology Molecules Target Profile
99 ACP1 2.08e-07 5.5 17 1621 202 104122 Polypharmacology Molecules Target Profile
100 ABCB1 1.01e-07 5.4 18 1621 216 104122 Polypharmacology Molecules Target Profile
101 HSP90AA1 9.27e-39 5.4 105 1621 1321 104122 Polypharmacology Molecules Target Profile
102 IDE 1.88e-20 5.4 53 1621 649 104122 Polypharmacology Molecules Target Profile
103 NPY2R 2.22e-55 5.3 155 1621 2021 104122 Polypharmacology Molecules Target Profile
104 PADI4 3.32e-19 5.3 50 1621 618 104122 Polypharmacology Molecules Target Profile
105 PREPL 6.85e-27 5.3 72 1621 902 104122 Polypharmacology Molecules Target Profile
106 MAPK1 1.59e-20 5.3 54 1621 672 104122 Polypharmacology Molecules Target Profile
107 AVPR1A 1.79e-10 5.3 26 1621 320 104122 Polypharmacology Molecules Target Profile
108 DLD 2.03e-20 5.1 56 1621 729 104122 Polypharmacology Molecules Target Profile
109 NPY1R 9.09e-48 4.8 147 1621 2112 104122 Polypharmacology Molecules Target Profile
110 ITGA4 1.41e-12 4.8 35 1621 476 104122 Polypharmacology Molecules Target Profile
111 CHRM4 1.85e-37 4.8 114 1621 1620 104122 Polypharmacology Molecules Target Profile
112 POLI 2.68e-28 4.8 85 1621 1198 104122 Polypharmacology Molecules Target Profile
113 KCNQ1 7.52e- 4.8 163 1621 2394 104122 Polypharmacology Molecules Target Profile
114 CHRM5 4.15e-29 4.7 88 1621 1247 104122 Polypharmacology Molecules Target Profile
115 CDC42 2.97e-05 4.6 13 1621 181 104122 Polypharmacology Molecules Target Profile
116 HCRTR1 3.84e-55 4.6 180 1621 2747 104122 Polypharmacology Molecules Target Profile
117 SELE 3.60e-16 4.6 48 1621 687 104122 Polypharmacology Molecules Target Profile
118 L3MBTL1 2.88e-14 4.5 43 1621 626 104122 Polypharmacology Molecules Target Profile
119 GALR3 8.51e-12 4.5 35 1621 510 104122 Polypharmacology Molecules Target Profile
120 NR5A1 1.35e-39 4.5 130 1621 1988 104122 Polypharmacology Molecules Target Profile
121 TDP2 3.88e-08 4.5 23 1621 334 104122 Polypharmacology Molecules Target Profile
122 DRD3 1.47e-78 4.4 281 1621 4742 104122 Polypharmacology Molecules Target Profile
123 CBX1 9.28e-16 4.4 49 1621 735 104122 Polypharmacology Molecules Target Profile
124 APOBEC3G 6.35e-21 4.4 67 1621 1015 104122 Polypharmacology Molecules Target Profile
125 COPS5 1.30e-09 4.2 30 1621 468 104122 Polypharmacology Molecules Target Profile
126 TP53 7.48e-21 4.1 71 1621 1138 104122 Polypharmacology Molecules Target Profile
127 TLR3 2.61e-05 4.1 15 1621 236 104122 Polypharmacology Molecules Target Profile
128 PPME1 1.98e-14 4.1 49 1621 795 104122 Polypharmacology Molecules Target Profile
129 AR 0.00078 4.0 10 1621 162 104122 Polypharmacology Molecules Target Profile
130 TUBB 1.04e-19 4.0 70 1621 1168 104122 Polypharmacology Molecules Target Profile
131 RAPGEF4 1.31e-05 3.9 17 1621 280 104122 Polypharmacology Molecules Target Profile
132 GBA 0.00014 3.9 13 1621 214 104122 Polypharmacology Molecules Target Profile
133 ALOX12 0.00015 3.9 13 1621 216 104122 Polypharmacology Molecules Target Profile
134 THRB 1.45e-05 3.9 17 1621 283 104122 Polypharmacology Molecules Target Profile
135 MCOLN3 1.50e-06 3.9 21 1621 353 104122 Polypharmacology Molecules Target Profile
136 SUMO1 2.93e-06 3.8 20 1621 338 104122 Polypharmacology Molecules Target Profile
137 HDAC3 0.00017 3.8 13 1621 219 104122 Polypharmacology Molecules Target Profile
138 MPI 4.83e-22 3.8 83 1621 1448 104122 Polypharmacology Molecules Target Profile
139 RBBP9 0.00017 3.8 13 1621 220 104122 Polypharmacology Molecules Target Profile
140 MBD2 2.11e-05 3.8 17 1621 292 104122 Polypharmacology Molecules Target Profile
141 PPP5C 2.11e-05 3.8 17 1621 292 104122 Polypharmacology Molecules Target Profile
142 CHRM1 5.23e-26 3.7 104 1621 1898 104122 Polypharmacology Molecules Target Profile
143 PTPN5 8.93e-05 3.7 15 1621 265 104122 Polypharmacology Molecules Target Profile
144 PSMD14 6.61e-13 3.6 50 1621 911 104122 Polypharmacology Molecules Target Profile
145 ATAD5 2.21e-60 3.5 285 1621 5984 104122 Polypharmacology Molecules Target Profile
146 TAAR1 8.61e-32 3.5 140 1621 2749 104122 Polypharmacology Molecules Target Profile
147 RAC1 9.32e-05 3.5 16 1621 299 104122 Polypharmacology Molecules Target Profile
148 MCL1 9.45e-41 3.4 188 1621 3830 104122 Polypharmacology Molecules Target Profile
149 WHSC1 2.52e-07 3.4 28 1621 533 104122 Polypharmacology Molecules Target Profile
150 PTK2 1.02e-09 3.4 39 1621 747 104122 Polypharmacology Molecules Target Profile
151 TRA@ 2.52e-05 3.4 19 1621 362 104122 Polypharmacology Molecules Target Profile
152 CYP1A2 0.0025 3.4 10 1621 192 104122 Polypharmacology Molecules Target Profile
153 POLH 5.68e-16 3.3 70 1621 1395 104122 Polypharmacology Molecules Target Profile
154 GNA15 9.63e-12 3.3 51 1621 1020 104122 Polypharmacology Molecules Target Profile
155 ALOX15B 7.60e-06 3.2 23 1621 462 104122 Polypharmacology Molecules Target Profile
156 STAT3 6.84e-26 3.2 128 1621 2739 104122 Polypharmacology Molecules Target Profile
157 PTGER2 6.98e-16 3.1 76 1621 1613 104122 Polypharmacology Molecules Target Profile
158 POLB 1.51e-17 3.1 86 1621 1847 104122 Polypharmacology Molecules Target Profile
159 CTNNB1 8.36e-05 3.1 19 1621 398 104122 Polypharmacology Molecules Target Profile
160 BAZ2B 2.57e-43 3.0 246 1621 5809 104122 Polypharmacology Molecules Target Profile
161 GNAS 0.0014 3.0 13 1621 279 104122 Polypharmacology Molecules Target Profile
162 THPO 1.46e-07 107.4 5 1621 3 104122 Polypharmacology Molecules Target Profile
163 CALM2 8.93e-05 96.5 3 1621 2 104122 Polypharmacology Molecules Target Profile
164 CALM1 8.93e-05 96.5 3 1621 2 104122 Polypharmacology Molecules Target Profile
165 NTSR2 8.93e-05 96.5 3 1621 2 104122 Polypharmacology Molecules Target Profile
166 CCNB1 0.00016 64.4 3 1621 3 104122 Polypharmacology Molecules Target Profile
167 TOP2A 0.00016 64.4 3 1621 3 104122 Polypharmacology Molecules Target Profile
168 CALM3 0.00016 64.4 3 1621 3 104122 Polypharmacology Molecules Target Profile
169 ARNT 0.0027 64.3 2 1621 2 104122 Polypharmacology Molecules Target Profile
170 TACR2 0.00028 48.3 3 1621 4 104122 Polypharmacology Molecules Target Profile
171 LHCGR 0.00028 48.3 3 1621 4 104122 Polypharmacology Molecules Target Profile
172 CCR5 0.0046 42.9 2 1621 3 104122 Polypharmacology Molecules Target Profile
173 OPRD1 6.50e-06 32.2 5 1621 10 104122 Polypharmacology Molecules Target Profile
174 FYN 0.00063 32.2 3 1621 6 104122 Polypharmacology Molecules Target Profile
175 LMNA 0.00086 27.6 3 1621 7 104122 Polypharmacology Molecules Target Profile
176 GALK1 2.35e-08 25.8 8 1621 20 104122 Polypharmacology Molecules Target Profile
177 MTOR 0.00012 25.8 4 1621 10 104122 Polypharmacology Molecules Target Profile
178 EGFR 0.00016 23.4 4 1621 11 104122 Polypharmacology Molecules Target Profile
179 MPHOSPH8 2.85e-05 21.5 5 1621 15 104122 Polypharmacology Molecules Target Profile
180 CACNB2 0.099 21.4 1 1621 3 104122 Polypharmacology Molecules Target Profile
181 GCK 0.099 21.4 1 1621 3 104122 Polypharmacology Molecules Target Profile
182 PARK2 0.099 21.4 1 1621 3 104122 Polypharmacology Molecules Target Profile
183 CACNA2D1 0.099 21.4 1 1621 3 104122 Polypharmacology Molecules Target Profile
184 CES2 0.099 21.4 1 1621 3 104122 Polypharmacology Molecules Target Profile
185 PIM2 0.099 21.4 1 1621 3 104122 Polypharmacology Molecules Target Profile
186 MAPK3 0.099 21.4 1 1621 3 104122 Polypharmacology Molecules Target Profile
187 CASP9 0.099 21.4 1 1621 3 104122 Polypharmacology Molecules Target Profile
188 DRD4 0.015 18.4 2 1621 7 104122 Polypharmacology Molecules Target Profile
189 RXRA 0.015 18.4 2 1621 7 104122 Polypharmacology Molecules Target Profile
190 SIGMAR1 0.015 18.4 2 1621 7 104122 Polypharmacology Molecules Target Profile
191 RGS16 1.45e-06 18.1 7 1621 25 104122 Polypharmacology Molecules Target Profile
192 RGS8 1.78e-06 17.4 7 1621 26 104122 Polypharmacology Molecules Target Profile
193 RGS7 0.00039 17.2 4 1621 15 104122 Polypharmacology Molecules Target Profile
194 HTR6 0.00039 17.2 4 1621 15 104122 Polypharmacology Molecules Target Profile
195 CHRM2 0.018 16.1 2 1621 8 104122 Polypharmacology Molecules Target Profile
196 TBXAS1 0.12 16.1 1 1621 4 104122 Polypharmacology Molecules Target Profile
197 AURKB 0.12 16.1 1 1621 4 104122 Polypharmacology Molecules Target Profile
198 CACNA1D 0.12 16.1 1 1621 4 104122 Polypharmacology Molecules Target Profile
199 CACNA1C 0.12 16.1 1 1621 4 104122 Polypharmacology Molecules Target Profile
200 ERBB2 0.12 16.1 1 1621 4 104122 Polypharmacology Molecules Target Profile
201 PLAU 0.12 16.1 1 1621 4 104122 Polypharmacology Molecules Target Profile
202 CACNA1S 0.12 16.1 1 1621 4 104122 Polypharmacology Molecules Target Profile
203 HRH4 0.12 16.1 1 1621 4 104122 Polypharmacology Molecules Target Profile
204 LCK 0.12 16.1 1 1621 4 104122 Polypharmacology Molecules Target Profile
205 METAP1 0.12 16.1 1 1621 4 104122 Polypharmacology Molecules Target Profile
206 RGS19 2.25e-05 14.9 6 1621 26 104122 Polypharmacology Molecules Target Profile
207 HTR2A 2.25e-05 14.9 6 1621 26 104122 Polypharmacology Molecules Target Profile
208 CYP3A5 0.00012 14.6 5 1621 22 104122 Polypharmacology Molecules Target Profile
209 CHRM3 0.00072 14.3 4 1621 18 104122 Polypharmacology Molecules Target Profile
210 CYP3A7 0.00072 14.3 4 1621 18 104122 Polypharmacology Molecules Target Profile
211 HRH2 0.0208 14.3 2 1621 9 104122 Polypharmacology Molecules Target Profile
212 HTR2C 3.72e-05 13.3 6 1621 29 104122 Polypharmacology Molecules Target Profile
213 CES1 0.14 12.9 1 1621 5 104122 Polypharmacology Molecules Target Profile
214 CASP8 0.14 12.9 1 1621 5 104122 Polypharmacology Molecules Target Profile
215 MAP3K5 0.14 12.9 1 1621 5 104122 Polypharmacology Molecules Target Profile
216 ADORA3 0.0011 12.3 4 1621 21 104122 Polypharmacology Molecules Target Profile
217 BCL2L2 1.31e-05 12.2 7 1621 37 104122 Polypharmacology Molecules Target Profile
218 ADRA2C 0.0057 12.1 3 1621 16 104122 Polypharmacology Molecules Target Profile
219 ADRA2A 0.0057 12.1 3 1621 16 104122 Polypharmacology Molecules Target Profile
220 STAT6 0.0067 11.4 3 1621 17 104122 Polypharmacology Molecules Target Profile
221 CYP2E1 0.0067 11.4 3 1621 17 104122 Polypharmacology Molecules Target Profile
222 NFKBIA 0.033 10.7 2 1621 12 104122 Polypharmacology Molecules Target Profile
223 G6PD 0.16 10.7 1 1621 6 104122 Polypharmacology Molecules Target Profile
224 PIM1 0.16 10.7 1 1621 6 104122 Polypharmacology Molecules Target Profile
225 CYP19A1 2.30e-06 10.2 9 1621 57 104122 Polypharmacology Molecules Target Profile
226 OPRM1 0.00015 9.9 6 1621 39 104122 Polypharmacology Molecules Target Profile
227 CYP2B7P1 0.038 9.9 2 1621 13 104122 Polypharmacology Molecules Target Profile
228 HTR2B 0.0025 9.5 4 1621 27 104122 Polypharmacology Molecules Target Profile
229 CYP2B6 0.043 9.2 2 1621 14 104122 Polypharmacology Molecules Target Profile
230 AOX1 0.16 9.2 1 1621 7 104122 Polypharmacology Molecules Target Profile
231 CYP2C18 0.16 9.2 1 1621 7 104122 Polypharmacology Molecules Target Profile
232 SLC22A2 0.16 9.2 1 1621 7 104122 Polypharmacology Molecules Target Profile
233 SLC47A1 0.16 9.2 1 1621 7 104122 Polypharmacology Molecules Target Profile
234 P4HB 2.62e-05 8.6 8 1621 60 104122 Polypharmacology Molecules Target Profile
235 SLC6A4 0.015 8.0 3 1621 24 104122 Polypharmacology Molecules Target Profile
236 ADRA2B 0.054 8.0 2 1621 16 104122 Polypharmacology Molecules Target Profile
237 PMM2 0.18 8.0 1 1621 8 104122 Polypharmacology Molecules Target Profile
238 APEX1 0.18 8.0 1 1621 8 104122 Polypharmacology Molecules Target Profile
239 BCL2 1.39e-05 8.0 9 1621 73 104122 Polypharmacology Molecules Target Profile
240 IL8 0.058 7.6 2 1621 17 104122 Polypharmacology Molecules Target Profile
241 MAOB 0.058 7.6 2 1621 17 104122 Polypharmacology Molecules Target Profile
242 ADRB1 0.21 7.1 1 1621 9 104122 Polypharmacology Molecules Target Profile
243 HTR7 0.21 7.1 1 1621 9 104122 Polypharmacology Molecules Target Profile
244 HRH1 0.0208 6.9 3 1621 28 104122 Polypharmacology Molecules Target Profile
245 PPARD 0.0208 6.9 3 1621 28 104122 Polypharmacology Molecules Target Profile
246 MLL 0.024 6.4 3 1621 30 104122 Polypharmacology Molecules Target Profile
247 SLC6A2 0.024 6.4 3 1621 30 104122 Polypharmacology Molecules Target Profile
248 BCHE 0.22 6.4 1 1621 10 104122 Polypharmacology Molecules Target Profile
249 CYP2D6 0.00052 6.2 7 1621 73 104122 Polypharmacology Molecules Target Profile
250 RORC 0.096 5.6 2 1621 23 104122 Polypharmacology Molecules Target Profile
251 GSTM1 0.00093 5.6 7 1621 81 104122 Polypharmacology Molecules Target Profile
252 MAOA 0.26 5.4 1 1621 12 104122 Polypharmacology Molecules Target Profile
253 EYA2 0.000701 5.1 8 1621 102 104122 Polypharmacology Molecules Target Profile
254 CYP2C8 0.046 4.9 3 1621 39 104122 Polypharmacology Molecules Target Profile
255 DAGLB 0.0044 4.8 6 1621 80 104122 Polypharmacology Molecules Target Profile
256 PIN1 0.3009 4.6 1 1621 14 104122 Polypharmacology Molecules Target Profile
257 PRKD1 0.0057 4.5 6 1621 85 104122 Polypharmacology Molecules Target Profile
258 CTBP1 0.0059 4.5 6 1621 86 104122 Polypharmacology Molecules Target Profile
259 RCE1 0.0082 4.2 6 1621 92 104122 Polypharmacology Molecules Target Profile
260 HRAS 0.0011 4.2 9 1621 139 104122 Polypharmacology Molecules Target Profile
261 PLEC 0.075 4.0 3 1621 48 104122 Polypharmacology Molecules Target Profile
262 ERG 0.15 4.0 2 1621 32 104122 Polypharmacology Molecules Target Profile
263 ADRA1D 0.33 4.0 1 1621 16 104122 Polypharmacology Molecules Target Profile
264 ADORA1 0.33 4.0 1 1621 16 104122 Polypharmacology Molecules Target Profile
265 KDM4A 0.34 3.8 1 1621 17 104122 Polypharmacology Molecules Target Profile
266 PTK2B 0.026 3.7 5 1621 88 104122 Polypharmacology Molecules Target Profile
267 MMP2 0.026 3.7 5 1621 88 104122 Polypharmacology Molecules Target Profile
268 RGS12 0.16 3.6 2 1621 36 104122 Polypharmacology Molecules Target Profile
269 CTSS 0.16 3.6 2 1621 36 104122 Polypharmacology Molecules Target Profile
270 CYP2A6 0.35 3.6 1 1621 18 104122 Polypharmacology Molecules Target Profile
271 HSPA5 0.36 3.4 1 1621 19 104122 Polypharmacology Molecules Target Profile
272 PPARG 0.063 3.3 4 1621 77 104122 Polypharmacology Molecules Target Profile
273 BCL2L10 0.037 3.3 5 1621 97 104122 Polypharmacology Molecules Target Profile
274 HBB 0.37 3.2 1 1621 20 104122 Polypharmacology Molecules Target Profile
275 RAD51 0.079 3.1 4 1621 83 104122 Polypharmacology Molecules Target Profile
276 CNR1 0.38 3.1 1 1621 21 104122 Polypharmacology Molecules Target Profile
277 CYP1A1 0.38 3.1 1 1621 21 104122 Polypharmacology Molecules Target Profile
278 ABCG2 0.013 3.0 8 1621 172 104122 Polypharmacology Molecules Target Profile
279 MBNL1 0.14 2.9 3 1621 66 104122 Polypharmacology Molecules Target Profile
280 DRD1 1.18e-35 2.9 216 1621 5292 104122 Polypharmacology Molecules Target Profile
281 SMARCA2 6.25e-12 2.9 64 1621 1473 104122 Polypharmacology Molecules Target Profile
282 KAT2A 0.0052 2.8 11 1621 250 104122 Polypharmacology Molecules Target Profile
283 MCOLN1 0.019 2.8 8 1621 184 104122 Polypharmacology Molecules Target Profile
284 FASN 1.55e-07 2.8 39 1621 909 104122 Polypharmacology Molecules Target Profile
285 FPR2 0.15 2.8 3 1621 69 104122 Polypharmacology Molecules Target Profile
286 S100A4 0.42 2.8 1 1621 23 104122 Polypharmacology Molecules Target Profile
287 CYP3A4 0.0027 2.8 13 1621 302 104122 Polypharmacology Molecules Target Profile
288 TARDBP 3.49e-16 2.8 95 1621 2298 104122 Polypharmacology Molecules Target Profile
289 NR1H4 0.25 2.7 2 1621 47 104122 Polypharmacology Molecules Target Profile
290 KCNH2 1.94e-06 2.7 35 1621 855 104122 Polypharmacology Molecules Target Profile
291 ADAM17 2.00e-09 2.6 56 1621 1391 104122 Polypharmacology Molecules Target Profile
292 ABCB6 0.0015 2.6 16 1621 394 104122 Polypharmacology Molecules Target Profile
293 ADAM10 2.20e-08 2.6 51 1621 1294 104122 Polypharmacology Molecules Target Profile
294 ADORA2A 0.44 2.6 1 1621 25 104122 Polypharmacology Molecules Target Profile
295 PIP4K2A 7.63e-07 2.5 43 1621 1130 104122 Polypharmacology Molecules Target Profile
296 DUSP1 0.13 2.5 4 1621 104 104122 Polypharmacology Molecules Target Profile
297 ADRBK1 0.000104 2.5 27 1621 712 104122 Polypharmacology Molecules Target Profile
298 ERAP1 0.3009 2.4 2 1621 53 104122 Polypharmacology Molecules Target Profile
299 MRGPRX1 1.12e-15 2.4 119 1621 3300 104122 Polypharmacology Molecules Target Profile
300 CASP6 0.04002 2.4 8 1621 214 104122 Polypharmacology Molecules Target Profile
301 EPHB4 0.106 2.4 5 1621 134 104122 Polypharmacology Molecules Target Profile
302 PLA2G7 1.13e-09 2.4 71 1621 1971 104122 Polypharmacology Molecules Target Profile
303 DRD2 2.63e-19 2.4 157 1621 4522 104122 Polypharmacology Molecules Target Profile
304 SLC5A7 6.68e-10 2.3 77 1621 2196 104122 Polypharmacology Molecules Target Profile
305 TSHR 9.00e-09 2.3 67 1621 1907 104122 Polypharmacology Molecules Target Profile
306 CGA 0.48 2.3 1 1621 28 104122 Polypharmacology Molecules Target Profile
307 BCL2L1 1.37e-05 2.3 40 1621 1147 104122 Polypharmacology Molecules Target Profile
308 SENP8 7.67e-12 2.3 101 1621 2986 104122 Polypharmacology Molecules Target Profile
309 RAPGEF3 0.041 2.2 9 1621 258 104122 Polypharmacology Molecules Target Profile
310 POLK 0.0023 2.2 20 1621 576 104122 Polypharmacology Molecules Target Profile
311 ARRB1 0.012 2.2 14 1621 407 104122 Polypharmacology Molecules Target Profile
312 KCNK9 4.53e-09 2.2 78 1621 2342 104122 Polypharmacology Molecules Target Profile
313 RORA 3.61e-05 2.1 42 1621 1290 104122 Polypharmacology Molecules Target Profile
314 DUSP3 0.0071 2.1 18 1621 552 104122 Polypharmacology Molecules Target Profile
315 PLA2G3 0.00052 2.1 30 1621 925 104122 Polypharmacology Molecules Target Profile
316 KDM4C 0.35 2.1 2 1621 62 104122 Polypharmacology Molecules Target Profile
317 SLC6A3 7.59e-05 2.1 41 1621 1290 104122 Polypharmacology Molecules Target Profile
318 PLK1 1.01e-12 2.1 135 1621 4381 104122 Polypharmacology Molecules Target Profile
319 LYPLA1 0.099 2.1 7 1621 218 104122 Polypharmacology Molecules Target Profile
320 GNAO1 0.00017 2.1 37 1621 1169 104122 Polypharmacology Molecules Target Profile
321 INS 2.16e-05 2.0 51 1621 1658 104122 Polypharmacology Molecules Target Profile
322 ALPPL2 0.00028 2.0 38 1621 1247 104122 Polypharmacology Molecules Target Profile
323 LYPLA2 0.027 2.0 14 1621 458 104122 Polypharmacology Molecules Target Profile
324 STAT1 4.33e-10 2.0 117 1621 3957 104122 Polypharmacology Molecules Target Profile
325 ATG4B 0.0018 2.0 29 1621 961 104122 Polypharmacology Molecules Target Profile
326 PRMT1 1.78e-05 1.9 57 1621 1919 104122 Polypharmacology Molecules Target Profile
327 ALPL 0.033 1.9 14 1621 469 104122 Polypharmacology Molecules Target Profile
328 SENP6 8.75e-07 1.9 77 1621 2631 104122 Polypharmacology Molecules Target Profile
329 ESR1 5.83e-06 1.9 67 1621 2302 104122 Polypharmacology Molecules Target Profile
330 RACGAP1 0.019 1.9 18 1621 614 104122 Polypharmacology Molecules Target Profile
331 PTPN7 0.23 1.9 4 1621 136 104122 Polypharmacology Molecules Target Profile
332 UHRF1 0.017 1.8 21 1621 750 104122 Polypharmacology Molecules Target Profile
333 AHR 5.53e-08 1.8 114 1621 4183 104122 Polypharmacology Molecules Target Profile
334 TRHR 0.0078 1.8 27 1621 973 104122 Polypharmacology Molecules Target Profile
335 HSPB1 0.57 1.8 1 1621 36 104122 Polypharmacology Molecules Target Profile
336 SNCA 0.22 1.8 5 1621 181 104122 Polypharmacology Molecules Target Profile
337 EHMT2 1.32e-17 1.8 318 1621 12582 104122 Polypharmacology Molecules Target Profile
338 EIF2AK3 0.23 1.8 5 1621 183 104122 Polypharmacology Molecules Target Profile
339 PTPN22 0.35 1.8 3 1621 110 104122 Polypharmacology Molecules Target Profile
340 CTDSP1 0.011 1.7 27 1621 1006 104122 Polypharmacology Molecules Target Profile
341 PTBP1 6.83e-07 1.7 110 1621 4205 104122 Polypharmacology Molecules Target Profile
342 NR3C1 0.36 1.7 3 1621 114 104122 Polypharmacology Molecules Target Profile
343 USP2 0.37 1.7 3 1621 115 104122 Polypharmacology Molecules Target Profile
344 VCAM1 0.31 1.7 4 1621 154 104122 Polypharmacology Molecules Target Profile
345 ESR2 0.018 1.7 27 1621 1048 104122 Polypharmacology Molecules Target Profile
346 PAFAH2 0.018 1.7 27 1621 1049 104122 Polypharmacology Molecules Target Profile
347 CREBBP 0.47 1.6 2 1621 80 104122 Polypharmacology Molecules Target Profile
348 GFER 1.39e-05 1.6 116 1621 4821 104122 Polypharmacology Molecules Target Profile
349 ALPI 0.21 1.6 8 1621 325 104122 Polypharmacology Molecules Target Profile
350 CCT2 0.62 1.6 1 1621 41 104122 Polypharmacology Molecules Target Profile
351 TMPRSS15 0.62 1.6 1 1621 41 104122 Polypharmacology Molecules Target Profile
352 KCNK3 0.029 1.6 29 1621 1202 104122 Polypharmacology Molecules Target Profile
353 SLC12A5 0.00201 1.6 62 1621 2598 104122 Polypharmacology Molecules Target Profile
354 CASP7 0.37 1.5 4 1621 168 104122 Polypharmacology Molecules Target Profile
355 CDC25B 0.51 1.5 2 1621 84 104122 Polypharmacology Molecules Target Profile
356 EPHX2 0.23 1.5 8 1621 339 104122 Polypharmacology Molecules Target Profile
357 CTSB 0.52 1.5 2 1621 86 104122 Polypharmacology Molecules Target Profile
358 ALDH1A1 1.53e-06 1.5 223 1621 10294 104122 Polypharmacology Molecules Target Profile
359 PRKACA 0.54 1.4 2 1621 89 104122 Polypharmacology Molecules Target Profile
360 HPGD 0.00024 1.4 128 1621 5844 104122 Polypharmacology Molecules Target Profile
361 CTSG 0.54 1.4 2 1621 91 104122 Polypharmacology Molecules Target Profile
362 SIRT5 0.34 1.4 7 1621 321 104122 Polypharmacology Molecules Target Profile
363 PTPN11 0.66 1.4 1 1621 46 104122 Polypharmacology Molecules Target Profile
364 TRPV1 0.44 1.4 4 1621 186 104122 Polypharmacology Molecules Target Profile
365 GLS 0.44 1.4 4 1621 187 104122 Polypharmacology Molecules Target Profile
366 PLA2G1B 0.19 1.4 16 1621 750 104122 Polypharmacology Molecules Target Profile
367 GSK3A 0.31 1.4 9 1621 423 104122 Polypharmacology Molecules Target Profile
368 BAP1 0.38 1.4 6 1621 282 104122 Polypharmacology Molecules Target Profile
369 WEE1 0.13 1.4 26 1621 1234 104122 Polypharmacology Molecules Target Profile
370 NR1I2 0.16 1.3 23 1621 1118 104122 Polypharmacology Molecules Target Profile
371 ALOX15 0.25 1.3 15 1621 729 104122 Polypharmacology Molecules Target Profile
372 EIF4H 0.14 1.3 29 1621 1415 104122 Polypharmacology Molecules Target Profile
373 MMP13 0.69 1.3 1 1621 49 104122 Polypharmacology Molecules Target Profile
374 NR4A1 0.61 1.3 2 1621 100 104122 Polypharmacology Molecules Target Profile
375 APOBEC3A 0.38 1.3 9 1621 453 104122 Polypharmacology Molecules Target Profile
376 PABPC1 0.13 1.3 40 1621 2030 104122 Polypharmacology Molecules Target Profile
377 MAP3K3 0.099 1.3 54 1621 2766 104122 Polypharmacology Molecules Target Profile
378 CACNA1H 0.054 1.3 78 1621 4011 104122 Polypharmacology Molecules Target Profile
379 CLK1 0.71 1.3 1 1621 51 104122 Polypharmacology Molecules Target Profile
380 PLCB3 0.49 1.2 7 1621 378 104122 Polypharmacology Molecules Target Profile
381 GAA 0.37 1.2 22 1621 1220 104122 Polypharmacology Molecules Target Profile
382 SENP7 0.26 1.2 47 1621 2622 104122 Polypharmacology Molecules Target Profile
383 BRCA1 0.36 1.1 33 1621 1879 104122 Polypharmacology Molecules Target Profile
384 RELA 0.76 1.1 1 1621 57 104122 Polypharmacology Molecules Target Profile
385 CASP3 0.38 1.1 36 1621 2079 104122 Polypharmacology Molecules Target Profile
386 PHOSPHO1 0.51 1.1 37 1621 2246 104122 Polypharmacology Molecules Target Profile
387 FGF22 0.66 1.0 8 1621 498 104122 Polypharmacology Molecules Target Profile
388 YWHAG 0.81 1.0 1 1621 65 104122 Polypharmacology Molecules Target Profile
389 KLK7 0.78 1.0 20 1621 1343 104122 Polypharmacology Molecules Target Profile
390 PAFAH1B2 0.78 1.0 22 1621 1480 104122 Polypharmacology Molecules Target Profile
391 ROCK2 0.78 0.9 3 1621 203 104122 Polypharmacology Molecules Target Profile
392 KPNA2 0.82 0.9 3 1621 212 104122 Polypharmacology Molecules Target Profile
393 PTH1R 0.85 0.9 2 1621 149 104122 Polypharmacology Molecules Target Profile
394 PLCG1 0.99 0.8 17 1621 1296 104122 Polypharmacology Molecules Target Profile
395 PKM 0.92 0.8 7 1621 537 104122 Polypharmacology Molecules Target Profile
396 CYP2C9 0.99 0.8 250 1621 19841 104122 Polypharmacology Molecules Target Profile
397 TSG101 0.93 0.8 1 1621 85 104122 Polypharmacology Molecules Target Profile
398 KLK5 0.99 0.7 11 1621 970 104122 Polypharmacology Molecules Target Profile
399 F2 0.99 0.7 4 1621 360 104122 Polypharmacology Molecules Target Profile
400 MARVELD2 0.99 0.7 4 1621 364 104122 Polypharmacology Molecules Target Profile
401 DRD5 0.99 0.6 1 1621 101 104122 Polypharmacology Molecules Target Profile
402 AKT1 0.99 0.6 10 1621 1113 104122 Polypharmacology Molecules Target Profile
403 SMN2 0.99 0.6 36 1621 4009 104122 Polypharmacology Molecules Target Profile
404 CYP2C19 0.99 0.5 181 1621 20089 104122 Polypharmacology Molecules Target Profile
405 F12 0.99 0.5 4 1621 538 104122 Polypharmacology Molecules Target Profile
406 NPC1 0.99 0.5 25 1621 3338 104122 Polypharmacology Molecules Target Profile
407 NR0B1 0.99 0.5 14 1621 1900 104122 Polypharmacology Molecules Target Profile
408 RXFP1 0.99 0.4 1 1621 143 104122 Polypharmacology Molecules Target Profile
409 MAPK10 0.99 0.4 2 1621 348 104122 Polypharmacology Molecules Target Profile
410 RAB9A 0.99 0.3 21 1621 4058 104122 Polypharmacology Molecules Target Profile
411 GSK3B 0.99 0.3 1 1621 226 104122 Polypharmacology Molecules Target Profile
412 ABCC1 0.99 0.2 2 1621 845 104122 Polypharmacology Molecules Target Profile
413 IDO1 0.99 0.0 0 1621 6 104122 Polypharmacology Molecules Target Profile
414 HSD11B1 0.99 0.0 0 1621 12 104122 Polypharmacology Molecules Target Profile
415 CA7 0.99 0.0 0 1621 19 104122 Polypharmacology Molecules Target Profile
416 CA12 0.99 0.0 0 1621 26 104122 Polypharmacology Molecules Target Profile
417 KEAP1 0.99 0.0 0 1621 7 104122 Polypharmacology Molecules Target Profile
418 GABRA1 0.99 0.0 0 1621 4 104122 Polypharmacology Molecules Target Profile
419 SCN9A 0.99 0.0 0 1621 4 104122 Polypharmacology Molecules Target Profile
420 NOX1 0.99 0.0 0 1621 13 104122 Polypharmacology Molecules Target Profile
421 PDE3A 0.99 0.0 0 1621 4 104122 Polypharmacology Molecules Target Profile
422 UGT1A9 0.99 0.0 0 1621 8 104122 Polypharmacology Molecules Target Profile
423 GRM5 0.99 0.0 0 1621 6 104122 Polypharmacology Molecules Target Profile
424 PTGDR 0.99 0.0 0 1621 6 104122 Polypharmacology Molecules Target Profile
425 AKR1C1 0.99 0.0 0 1621 6 104122 Polypharmacology Molecules Target Profile
426 UGT1A3 0.99 0.0 0 1621 4 104122 Polypharmacology Molecules Target Profile
427 CYP1B1 0.99 0.0 0 1621 10 104122 Polypharmacology Molecules Target Profile
428 CA5B 0.99 0.0 0 1621 16 104122 Polypharmacology Molecules Target Profile
429 SLC47A2 0.99 0.0 0 1621 5 104122 Polypharmacology Molecules Target Profile
430 TYMS 0.99 0.0 0 1621 6 104122 Polypharmacology Molecules Target Profile
431 HCRTR2 0.99 0.0 0 1621 28 104122 Polypharmacology Molecules Target Profile
432 CA14 0.99 0.0 0 1621 21 104122 Polypharmacology Molecules Target Profile
433 HTR1F 0.99 0.0 0 1621 4 104122 Polypharmacology Molecules Target Profile
434 CA3 0.99 0.0 0 1621 14 104122 Polypharmacology Molecules Target Profile
435 PTGER4 0.99 0.0 0 1621 9 104122 Polypharmacology Molecules Target Profile
436 ATP1A1 0.99 0.0 0 1621 6 104122 Polypharmacology Molecules Target Profile
437 SLC22A1 0.99 0.0 0 1621 5 104122 Polypharmacology Molecules Target Profile
438 ADORA2B 0.99 0.0 0 1621 9 104122 Polypharmacology Molecules Target Profile
439 ACHE 0.99 0.0 0 1621 13 104122 Polypharmacology Molecules Target Profile
440 FKBP1A 0.99 0.0 0 1621 22 104122 Polypharmacology Molecules Target Profile
441 UGT2B7 0.99 0.0 0 1621 4 104122 Polypharmacology Molecules Target Profile
442 PPARA 0.99 0.0 0 1621 6 104122 Polypharmacology Molecules Target Profile
443 HTR1D 0.99 0.0 0 1621 8 104122 Polypharmacology Molecules Target Profile
444 UGT1A1 0.99 0.0 0 1621 5 104122 Polypharmacology Molecules Target Profile
445 CYP11B1 0.99 0.0 0 1621 8 104122 Polypharmacology Molecules Target Profile
446 HTR1B 0.99 0.0 0 1621 6 104122 Polypharmacology Molecules Target Profile
447 PTGS2 0.99 0.0 0 1621 19 104122 Polypharmacology Molecules Target Profile
448 NR3C2 0.99 0.0 0 1621 7 104122 Polypharmacology Molecules Target Profile
449 F11 0.99 0.0 0 1621 293 104122 Polypharmacology Molecules Target Profile
450 MMP9 0.99 0.0 0 1621 5 104122 Polypharmacology Molecules Target Profile
451 PDE4A 0.99 0.0 0 1621 8 104122 Polypharmacology Molecules Target Profile
452 PDE4B 0.99 0.0 0 1621 7 104122 Polypharmacology Molecules Target Profile
453 KCNMA1 0.99 0.0 0 1621 6 104122 Polypharmacology Molecules Target Profile
454 AVPR1B 0.99 0.0 0 1621 57 104122 Polypharmacology Molecules Target Profile
455 AKR1B1 0.99 0.0 0 1621 4 104122 Polypharmacology Molecules Target Profile
456 ABCC8 0.99 0.0 0 1621 4 104122 Polypharmacology Molecules Target Profile
457 SLC12A3 0.99 0.0 0 1621 9 104122 Polypharmacology Molecules Target Profile
458 CA2 0.99 0.0 0 1621 30 104122 Polypharmacology Molecules Target Profile
459 CA5A 0.99 0.0 0 1621 18 104122 Polypharmacology Molecules Target Profile
460 CNR2 0.99 0.0 0 1621 7 104122 Polypharmacology Molecules Target Profile
461 SLC12A1 0.99 0.0 0 1621 5 104122 Polypharmacology Molecules Target Profile
462 ERAP2 0.99 0.0 0 1621 4 104122 Polypharmacology Molecules Target Profile
463 SCN5A 0.99 0.0 0 1621 9 104122 Polypharmacology Molecules Target Profile
464 CYP11B2 0.99 0.0 0 1621 6 104122 Polypharmacology Molecules Target Profile
465 CA1 0.99 0.0 0 1621 33 104122 Polypharmacology Molecules Target Profile
466 RXFP2 0.99 0.0 0 1621 55 104122 Polypharmacology Molecules Target Profile
467 PGR 0.99 0.0 0 1621 7 104122 Polypharmacology Molecules Target Profile
468 AKR1C3 0.99 0.0 0 1621 10 104122 Polypharmacology Molecules Target Profile
469 PTPN12 0.99 0.0 0 1621 4 104122 Polypharmacology Molecules Target Profile
470 CA6 0.99 0.0 0 1621 18 104122 Polypharmacology Molecules Target Profile
471 CA9 0.99 0.0 0 1621 28 104122 Polypharmacology Molecules Target Profile
472 MMP12 0.99 0.0 0 1621 5 104122 Polypharmacology Molecules Target Profile
473 AKR1C2 0.99 0.0 0 1621 6 104122 Polypharmacology Molecules Target Profile
474 KIF11 0.99 0.0 0 1621 4 104122 Polypharmacology Molecules Target Profile
475 METAP2 0.99 0.0 0 1621 4 104122 Polypharmacology Molecules Target Profile
476 GPR32 0.99 0.0 0 1621 19 104122 Polypharmacology Molecules Target Profile
477 HSD17B1 0.99 0.0 0 1621 5 104122 Polypharmacology Molecules Target Profile
478 C1S 0.99 0.0 0 1621 96 104122 Polypharmacology Molecules Target Profile
479 PTGS1 0.99 0.0 0 1621 19 104122 Polypharmacology Molecules Target Profile
480 PDE5A 0.99 0.0 0 1621 4 104122 Polypharmacology Molecules Target Profile
481 SHBG 0.99 0.0 0 1621 18 104122 Polypharmacology Molecules Target Profile
482 GPER 0.99 0.0 0 1621 19 104122 Polypharmacology Molecules Target Profile
483 PTGIR 0.99 0.0 0 1621 8 104122 Polypharmacology Molecules Target Profile
484 ADRA1A 0.99 0.0 0 1621 8 104122 Polypharmacology Molecules Target Profile
485 XIAP 0.99 0.0 0 1621 18 104122 Polypharmacology Molecules Target Profile
486 CA13 0.99 0.0 0 1621 7 104122 Polypharmacology Molecules Target Profile
487 GLA 0.99 0.0 0 1621 19 104122 Polypharmacology Molecules Target Profile
488 GRM1 0.99 0.0 0 1621 4 104122 Polypharmacology Molecules Target Profile
489 MYC 0.99 0.0 0 1621 25 104122 Polypharmacology Molecules Target Profile
490 PTPN1 0.99 0.0 0 1621 4 104122 Polypharmacology Molecules Target Profile
491 SMN1 0.99 0.0 0 1621 4 104122 Polypharmacology Molecules Target Profile
492 MPO 0.99 0.0 0 1621 6 104122 Polypharmacology Molecules Target Profile
493 CA4 0.99 0.0 0 1621 22 104122 Polypharmacology Molecules Target Profile
494 MEN1 0.99 0.0 0 1621 5 104122 Polypharmacology Molecules Target Profile
495 HK1 0.99 0.0 0 1621 7 104122 Polypharmacology Molecules Target Profile
496 ID4 0.99 0.0 0 1621 29 104122 Polypharmacology Molecules Target Profile
497 GRM4 0.99 0.0 0 1621 21 104122 Polypharmacology Molecules Target Profile
498 EZH2 0.99 0.0 0 1621 7 104122 Polypharmacology Molecules Target Profile
499 ADRA1B 0.99 0.0 0 1621 5 104122 Polypharmacology Molecules Target Profile
500 MAPK14 0.99 0.0 0 1621 8 104122 Polypharmacology Molecules Target Profile
501 ALOX5 0.99 0.0 0 1621 7 104122 Polypharmacology Molecules Target Profile
502 SMPD1 0.99 0.0 0 1621 10 104122 Polypharmacology Molecules Target Profile
503 FPR1 0.99 0.0 0 1621 172 104122 Polypharmacology Molecules Target Profile
504 PTGDR2 0.99 0.0 0 1621 6 104122 Polypharmacology Molecules Target Profile